LEESBURG, Va.--(BUSINESS WIRE)--K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced that it has entered the next generation of materials technology in the spine market. Biomaterials is a rapidly expanding sector of the spinal industry that uses polymers and biological materials for bone grafting instead of the metals commonly used for spinal fusions. Biological materials allow for increased cellular activity, growth and differentiation which may increase bone formation and stimulate a spinal fusion.
